Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996340424> ?p ?o ?g. }
- W1996340424 endingPage "234" @default.
- W1996340424 startingPage "227" @default.
- W1996340424 abstract "Cerebellar dysplasia with cysts (CDC) is an imaging finding typically seen in combination with cobblestone cortex and congenital muscular dystrophy in individuals with dystroglycanopathies. More recently, CDC was reported in seven children without neuromuscular involvement (Poretti-Boltshauser syndrome). Using a combination of homozygosity mapping and whole-exome sequencing, we identified biallelic mutations in LAMA1 as the cause of CDC in seven affected individuals (from five families) independent from those included in the phenotypic description of Poretti-Boltshauser syndrome. Most of these individuals also have high myopia, and some have retinal dystrophy and patchy increased T2-weighted fluid-attenuated inversion recovery (T2/FLAIR) signal in cortical white matter. In one additional family, we identified two siblings who have truncating LAMA1 mutations in combination with retinal dystrophy and mild cerebellar dysplasia without cysts, indicating that cysts are not an obligate feature associated with loss of LAMA1 function. This work expands the phenotypic spectrum associated with the lamininopathy disorders and highlights the tissue-specific roles played by different laminin-encoding genes. Cerebellar dysplasia with cysts (CDC) is an imaging finding typically seen in combination with cobblestone cortex and congenital muscular dystrophy in individuals with dystroglycanopathies. More recently, CDC was reported in seven children without neuromuscular involvement (Poretti-Boltshauser syndrome). Using a combination of homozygosity mapping and whole-exome sequencing, we identified biallelic mutations in LAMA1 as the cause of CDC in seven affected individuals (from five families) independent from those included in the phenotypic description of Poretti-Boltshauser syndrome. Most of these individuals also have high myopia, and some have retinal dystrophy and patchy increased T2-weighted fluid-attenuated inversion recovery (T2/FLAIR) signal in cortical white matter. In one additional family, we identified two siblings who have truncating LAMA1 mutations in combination with retinal dystrophy and mild cerebellar dysplasia without cysts, indicating that cysts are not an obligate feature associated with loss of LAMA1 function. This work expands the phenotypic spectrum associated with the lamininopathy disorders and highlights the tissue-specific roles played by different laminin-encoding genes. Cerebellar dysplasia is a neuroimaging finding that describes abnormalities of both the cerebellar cortex and white matter and is associated with variable neurodevelopmental outcome.1Demaerel P. Abnormalities of cerebellar foliation and fissuration: classification, neurogenetics and clinicoradiological correlations.Neuroradiology. 2002; 44: 639-646Crossref PubMed Scopus (62) Google Scholar, 2Jissendi-Tchofo P. Pandit F. Soto-Ares G. Vallee L. Neuropsychological evaluation and follow-up of children with cerebellar cortical dysplasia.Dev. Med. Child Neurol. 2011; 53: 1119-1127Crossref PubMed Scopus (7) Google Scholar, 3Poretti A. Boltshauser E. Cerebellar dysplasia.in: Boltshauser E. Schmahmann J. Cerebellar disorders in children. Mac Keith Press, London2012: 172-176Google Scholar, 4Soto-Ares G. Delmaire C. Deries B. Vallee L. Pruvo J.P. Cerebellar cortical dysplasia: MR findings in a complex entity.AJNR Am. J. Neuroradiol. 2000; 21: 1511-1519PubMed Google Scholar Cerebellar dysplasia is presumed to arise through genetic or acquired developmental defects that affect cerebellar foliation and fissure formation.5Boddaert N. Desguerre I. Bahi-Buisson N. Romano S. Valayannopoulos V. Saillour Y. Seidenwurm D. Grevent D. Berteloot L. Lebre A.S. et al.Posterior fossa imaging in 158 children with ataxia.J. Neuroradiol. 2010; 37: 220-230Crossref PubMed Scopus (26) Google Scholar Although in most cases the etiology of generalized cerebellar hemisphere dysplasia is unknown, this imaging finding has been reported in congenital muscular dystrophies (CMDs), most notably POMGNT1-related CMD (MIM 606822),6Poretti A. Klein A. Boltshauser E. Cerebellar cysts and neuroimaging in congenital muscular dystrophies.in: Boltshauser E. Schmahmann J. Cerebellar disorders in children. Mac Keith Press, London2012: 177-183Google Scholar and in Chudley-McCullough syndrome (MIM 604213). Although generally rare, cerebellar cysts are frequently identified in individuals with CMD.6Poretti A. Klein A. Boltshauser E. Cerebellar cysts and neuroimaging in congenital muscular dystrophies.in: Boltshauser E. Schmahmann J. Cerebellar disorders in children. Mac Keith Press, London2012: 177-183Google Scholar Recently, a distinctive cerebellar dysplasia with cysts (CDC) phenotype was described in seven children (from five families) with ataxia, intellectual disability, and language impairment but without significant muscle disease (Poretti-Boltshauser syndrome).7Poretti A. Häusler M. von Moers A. Baumgartner B. Zerres K. Klein A. Aiello C. Moro F. Zanni G. Santorelli F.M. et al.Ataxia, intellectual disability, and ocular apraxia with cerebellar cysts: a new disease?.Cerebellum. 2014; 13: 79-88Crossref PubMed Scopus (37) Google Scholar Although the nine genes in which loss-of-function mutations have been shown to cause CMD (POMT1 [MIM 607423], POMT2 [MIM 607439], POMGNT1, FKRP [MIM 606596], FKTN [MIM 607440], LARGE [MIM 603590], ISPD [MIM 614631], B3GALNT2 [MIM 610194], and GPR56 [MIM 604110]) were sequenced in these seven children, the genetic cause of CDC was not identified. Here, we report that mutations in LAMA1 (MIM 150320; RefSeq accession number NM_005559.3), encoding laminin subunit α1, cause CDC, and we expand the phenotype to include milder brain-imaging findings and retinal dystrophy. Initially, we enrolled a series of three CDC-affected individuals from three families under informed consent through human-subjects-research protocols approved by the institutional review boards at the University of Washington and the University of Calgary. The phenotype of these individuals is indistinguishable from that described in Poretti-Boltshauser syndrome.7Poretti A. Häusler M. von Moers A. Baumgartner B. Zerres K. Klein A. Aiello C. Moro F. Zanni G. Santorelli F.M. et al.Ataxia, intellectual disability, and ocular apraxia with cerebellar cysts: a new disease?.Cerebellum. 2014; 13: 79-88Crossref PubMed Scopus (37) Google Scholar To identify the genetic cause of CDC in these individuals, we combined homozygosity mapping and exome sequencing. Genome-wide SNP genotyping was performed with the Affymetrix Genome-wide Human SNP Array 6.0 on peripheral-blood DNA from CA0035 (II-3 in Figure 1B), whose parents are first cousins. Using HomozygosityMapper,8Seelow D. Schuelke M. Hildebrandt F. Nürnberg P. HomozygosityMapper—an interactive approach to homozygosity mapping.Nucleic Acids Res. 2009; 37: W593-W599Crossref PubMed Scopus (300) Google Scholar we identified ten copy-number-neutral homozygosity regions (Figure 1A) spanning >10 Mb, including a 15.9 Mb stretch in chromosomal region 18p11.31–p11.2 between markers rs1940954 and rs2850205. We then performed whole-exome sequencing on peripheral-blood DNA from all three individuals (Table S1, available online), as described previously.9Srour M. Putorti M.L. Schwartzentruber J. Bolduc V. Shevell M.I. Poulin C. O’Ferrall E. Buhas D. Majewski J. Brais B. FORGE consortiumMutations in riboflavin transporter present with severe sensory loss and deafness in childhood.Muscle Nerve. 2014; (Published online February 24, 2014)https://doi.org/10.1002/mus.24224Crossref PubMed Scopus (18) Google Scholar In brief, genomic DNA was captured with the Agilent SureSelect v.5 exome capture oligonucleotide library and sequenced with paired-end 100 bp reads on Illumina HiSeq 2000. TTN (MIM 188840) and LAMA1 were the only genes found to harbor rare (<5% in 1000 Genomes), deleterious variants in all affected individuals and lie within homozygous regions identified in CA0035 (Table S2 and Figure 1A). Because TTN is a very large gene that frequently harbors variants mainly as a result of its large size, and no individuals with CDC have the dilated or hypertrophic cardiomyopathy that has been associated with TTN mutations, it was excluded from consideration. The LAMA1 variants are not present in 1000 Genomes, the NHLBI Exome Sequencing Project Exome Variant Server (EVS), dbSNP version 137, or an in-house exome database consisting of ∼2,000 samples and are predicted to truncate the protein or result in aberrant splicing by Human Splicing Finder v.3.0.10Desmet F.O. Hamroun D. Lalande M. Collod-Béroud G. Claustres M. Béroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals.Nucleic Acids Res. 2009; 37: e67Crossref PubMed Scopus (1916) Google Scholar CA0035 carries a homozygous canonical splice variant in the donor site for exon 5 of LAMA1 (c.588+2T>G). UW162-3 (II-3 in Figure 1B) carries a heterozygous 13 bp deletion (c.7965−15_7965−3del) that is predicted to alter splicing and a heterozygous 1 bp deletion (c.2988_2989delA) that is predicted to cause a frameshift and premature truncation of the protein (p.Thr996Hisfs28∗). UW154-3 (II-3 in Figure 1B) carries a single heterozygous variant at the third nucleotide of the splice donor site in intron 44 of LAMA1 (c.6345+3G>C). This mutation results in a transcript that is missing exon 45 (Figure 1D) and is predicted to generate a truncated protein (p.Thr2064Ansfs∗2). These variants were confirmed by Sanger sequencing and segregated appropriately in the families (Figure 1B and Figure S1). Because we identified only a single LAMA1 variant in UW154-3, we hypothesized that a heterozygous deletion in LAMA1 might be present. We used the whole-exome sequencing data to analyze copy-number variants (CNVs) with FishingCNV.11Shi Y. Majewski J. FishingCNV: a graphical software package for detecting rare copy number variations in exome-sequencing data.Bioinformatics. 2013; 29: 1461-1462Crossref PubMed Scopus (38) Google Scholar To identify rare CNVs, we used the same exome sequencing protocol to compare the read depth of the variants in UW154-3 against the distribution of reads in more than 50 control individuals with unrelated genetic disorders. This analysis identified a significant heterozygous LAMA1 deletion variant (p = 4.98 × 10−45) spanning exons 4–11 (chr18: 7,038,808–7,050,935, hg19). There is a long tandem repeat (L1MA9) on the centromeric side, but not on the telomeric side, of this CNV. No deletion at this position has been reported in the Database of Genomic Variants.12MacDonald J.R. Ziman R. Yuen R.K. Feuk L. Scherer S.W. The Database of Genomic Variants: a curated collection of structural variation in the human genome.Nucleic Acids Res. 2014; 42: D986-D992Crossref PubMed Scopus (766) Google Scholar Quantitative PCR confirmed the deletion and found that it was paternally inherited (Figure S2). In parallel, we performed exome sequencing in a cohort of 40 individuals with a clinical diagnosis of Joubert syndrome (MIM 213300) and in whom targeted sequencing had excluded mutations in all published genes implicated in Joubert and Meckel syndromes (NPHP1 [MIM 607100], AHI1 [MIM 608894], CEP290 [MIM 610142], RPGRIP1L [MIM 610937], TMEM67 [MIM 609884], CC2D2A [MIM 612013], ARL13B [MIM 608922], INPP5E [MIM 613037], OFD1 [MIM 300170], TMEM216 [MIM 613277], CEP41 [MIM 610523], TMEM237 [MIM 614423], TCTN2 [MIM 613846], KIF7 [MIM 611254], TCTN1 [MIM 609863], TMEM138 [MIM 614459], MKS1 [MIM 609883], C5ORF42 [MIM 614571], TMEM231 [MIM 614949], TCTN3 [MIM 613847], CSPP1 [MIM 611654], PDE6D [MIM 602676], IFT172 [MIM 607386], ZNF423 [MIM 604557], TTC21B [MIM 612014], B9D1 [MIM 614144], and B9D2 [MIM 611951]). Joubert syndrome is a recessive neurodevelopmental disorder typically defined by a pathognomonic brain malformation: “the molar-tooth sign,” which consists of cerebellar vermis hypoplasia, thickened, horizontally oriented superior cerebellar peduncles, and sometimes a deep interpeduncular fossa.13Maria B.L. Hoang K.B. Tusa R.J. Mancuso A.A. Hamed L.M. Quisling R.G. Hove M.T. Fennell E.B. Booth-Jones M. Ringdahl D.M. et al.“Joubert syndrome” revisited: key ocular motor signs with magnetic resonance imaging correlation.J. Child Neurol. 1997; 12: 423-430Crossref PubMed Scopus (259) Google Scholar CDC and Joubert syndrome share nonspecific clinical features, including cognitive impairment, hypotonia, ataxia, and abnormal eye movements, but CDC does not manifest with the alternating tachypnea and apnea often seen in Joubert syndrome. Some individuals with Joubert syndrome also develop progressive retinal dystrophy, cystic kidney disease, and/or liver fibrosis that result in significant morbidity and mortality. Surprisingly, exome sequencing in one of the families previously diagnosed with Joubert syndrome revealed in one affected sibling (UW160-3 [II-3 in Figure 1B]) four rare LAMA1 variants, three of which were maternally inherited (c.8557–1G>C [in 0/13,006 EVS chromosomes], c.2657C>T [p.Ala886Val] [in 34/13,006 EVS chromosomes, PolyPhen-2 scores 0.907 and 0.753], and c.768+1G>A [in 0/13,006 EVS chromosomes]) and one of which was paternally inherited (c.6701delC [p.Pro2334Leufs9∗]). Sanger sequencing confirmed that the other affected sibling (UW160-4 [II-4 in Figure 1B]) also carries all four variants. In a second family with two siblings (UW163-3 and UW163-4) previously diagnosed with mild Joubert syndrome, we identified compound-heterozygous mutations (the paternally inherited c.2816_2817delAT [p.Tyr939Leufs27∗] and the maternally inherited c.555T>G [p.Tyr185∗] [in 0/13,006 EVS chromosomes]) in LAMA1 in UW163-3. Sanger sequencing confirmed that the other affected sibling (UW163-4) shares these variants in LAMA1. We reviewed the clinical and imaging features for the affected individuals from all five families (Table 1). Four individuals showed classic CDC findings, including cerebellar dysplasia with cysts (more severe rostrally and ventrally) and cerebellar vermis hypoplasia. In three, the superior cerebellar peduncles were elevated and splayed, and the fourth ventricle was elongated rostrocaudally and laterally (Figure 2). Minor abnormalities of the brainstem included a short pons (CA0035 and UW154-3), narrow isthmus (UW154-3 and UW160-4), and long midbrain (UW154-3). Although UW160-4 had somewhat long superior cerebellar peduncles, they were not classic for the molar-tooth appearance that defines Joubert syndrome.13Maria B.L. Hoang K.B. Tusa R.J. Mancuso A.A. Hamed L.M. Quisling R.G. Hove M.T. Fennell E.B. Booth-Jones M. Ringdahl D.M. et al.“Joubert syndrome” revisited: key ocular motor signs with magnetic resonance imaging correlation.J. Child Neurol. 1997; 12: 423-430Crossref PubMed Scopus (259) Google Scholar Similarly, UW163-3 and UW163-4 were previously categorized as having mild Joubert syndrome without the classic molar-tooth sign. A few supratentorial abnormalities present on imaging included a single periventricular heterotopia in CA0035 (Figure 2E), partial agenesis of the corpus callosum (a missing rostrum and a markedly thin isthmus and splenium) and partial absence of the septum pellucidum in UW154-3 (Figures 2I and 2J), and patchy increased T2-weighted fluid-attenuated inversion recovery (T2/FLAIR) in CA0035 and UW154-3 (Figures 2E and 2J). Notably, four affected individuals had large eye globes, consistent with high myopia (>−6 diopters). In contrast, UW163-3 and UW163-4 had superior cerebellar dysplasia without cysts (Figure 2L) and mild vermis hypoplasia (Figure 2N). UW163-3 also had patchy increased T2/FLAIR (Figure 2O) and a suprasellar arachnoid cyst, whereas UW163-4 had slightly elevated superior cerebellar peduncles and large globes (data not shown).Table 1Brain MRI Features in Affected Individuals with LAMA1 MutationsCA0035UW154-3UW162-3UW160-4UW163-3UW163-4cDNA mutation 1c.588+2T>Gc.6345+3G>C (maternal)c.7965−15_7965−3del (paternal)c.6701delC (paternal)c.2816_2817delAT (paternal)c.2816_2817delAT (paternal)Protein alteration 1canonical splicesplicesplicep.Pro2334Leufs9∗p.Tyr939Leufs27∗p.Tyr939Leufs27∗cDNA mutation 2c.588+2T>Gdeletion of exons 4–11 (paternal)c.2988_2989delA (maternal)c.8557−1G>C, c.768+1G>A (maternal)c.555T>G (maternal)c.555T>G (maternal)Protein alteration 2canonical spliceNAp.Pro996Hisfs28∗splice, splicep.Tyr185∗p.Thr185∗Age at MRI8 months5 and 15 months9 monthsunknown25 months5 monthsCerebellar dysplasiayesyesyesyessuperior onlysuperior onlyCerebellar cystsyesyesyesyesnonoVermis hypoplasiaglobalglobalglobalglobalinferior onlyinferior onlySCPselevated and splayedelevated and splayednormalelevated and splayednormalslightly elevatedFourth ventricleenlargedenlargedenlargedenlargedmildly enlargednormalBrainstemshort pons, thin isthmusshort pons, long midbrain, mildly enlarged tectumnormalthin isthmusmass effect from arachnoid cystnormalVentriclesnormalmoderate VM, partial agenesis of CC and SPnormalnormalnormalnormalEyeslargelargelargelargenormallargeIncreased T2/FLAIR in white matterpatchy increased, periventricularpatchy increased, periventricularnormalnormalpatchy increased, periventricularnormalOtherheterotopia in right lateral ventricleNANANAsuprasellar and interpeduncular cystNAAbbreviations are as follows: CC, corpus callosum; NA, not applicable; SCP, superior cerebellar peduncle; SP, septum pellucidum; and VM, ventricuolmegaly. Open table in a new tab Abbreviations are as follows: CC, corpus callosum; NA, not applicable; SCP, superior cerebellar peduncle; SP, septum pellucidum; and VM, ventricuolmegaly. All seven affected individuals had a history of motor delay, three had speech delay, and one was diagnosed with Asperger syndrome, but one was able to graduate from college and live independently as an adult (Table 2). All individuals also had abnormal eye movements, myopia (five with high myopia), and retinal differences, including thinning (UW154-3), atrophy (CA0035 and UW160-4), absent pigment (UW162-3), and overt early-onset retinal dystrophy with visual impairment (UW160-3) and abnormal electroretinography (ERG) (UW163-3 and UW163-4). UW160-3 also had macular heterotopia, and UW160-4 had bilateral cataracts noted at 22 years of age. Creatine kinase levels were not substantially elevated in three individuals, and no other clinical features were observed in more than one individual. The individuals previously diagnosed with Joubert syndrome did not display evidence of cystic kidney disease, liver fibrosis, polydactyly, coloboma, or other clinical features associated with Joubert syndrome.Table 2Clinical Features in Affected Individuals with LAMA1 MutationsCA0035UW154-3UW162-3UW160-3UW160-4UW163-3UW163-4EthnicityIranianmixed Europeanmixed Europeanmixed Europeanmixed EuropeanAsian and African AmericanAsian and African AmericanSexfemalefemalemalefemalemalefemalefemaleAge36 months36 months25 months29 years23 years5.5 years4.5 yearsOFC (age)50th percentile (12 months)>98th percentile (36 months)20th percentile (17 months)50th percentile (8 years)30th percentile (29 months)35th percentile (29 months)35th percentile (16 months)Height or length (age)90th percentile (12 months)4th percentile (36 months)60th percentile (17 months)155 cm (adult)168 cm (adult)60th percentile (25 months)40th percentile (16 months)Weight (age)97th percentile (12 months)65th percentile (36 months)25th percentile (17 months)77 kg (adult)93 kg (adult)60th percentile (25 months)30th percentile (16 months)NDVmoderate motor and speech delaymoderate motor delay (no standing or walking), mild speech delaymotor delay (cruising, but no walking), hypotoniahistory of motor delay, normal speech, normal IQ, college graduate, lives independentlyhistory of motor and speech delay, normal IQ, autism spectrum disorder (Asperger), lives with parentsmild motor and speech delay, hypotoniamotor and speech delay, hypotoniaEye movementsstrabismus, amblyopiastrabismus, nystagmusstrabismus, nystagmusstrabismus, OMAstrabismus, amblyopiaOMAOMA, strabismus S/P surgery, nystagmusRetinaatrophic appearingthinnedabsent pigmentlattice and peripheral degeneration, macular heterotopia, increased pigmentatrophic appearingretinal dysfunction: cones more affected than rods on ERGchorioretinal atrophy, macular and peripheral involvement, cones worse than rods on ERGAcuityhigh myopia (−13.5)high myopia (−17)myopiahigh myopia (−16.5)high myopia (−13.5)Myopia (−3.00)high myopia (−11.5)CK (ref.)177 (0–170 IU/l)53 (26–40 IU/l)141 (24–204 IU/l)NDNDNDNDOtheraminoaciduria, consanguinityone partial seizure (on Keppra), maternally inherited heterozygous 800 kb deletion: 10p12.1–p12.2mother on Clomid, normal SNP arrayfatty liver on ultrasound, syndactyly in second and third toesbilateral cataracts at 22 years old, possibly echogenic liver on ultrasound, syndactyly in second and third toesNANAAbbreviations are as follows: CK, creatine kinase; ERG, electroretinography; NA, not applicable; ND, not done; NDV, neurodevelopmental features; OMA, oculomotor apraxia; ref., reference; and S/P, status post. Open table in a new tab Abbreviations are as follows: CK, creatine kinase; ERG, electroretinography; NA, not applicable; ND, not done; NDV, neurodevelopmental features; OMA, oculomotor apraxia; ref., reference; and S/P, status post. LAMA1-related CDC contributes to the growing list of phenotypes associated with loss of function of laminin-encoding genes. An overlapping spectrum of posterior predominant brain phenotypes are characteristic of mutations in LAMA2 (MIM 156225), LAMB1 (MIM 150240), LAMC1 (MIM 150290), and LAMC3 (MIM 604349) and range from occipital cortical defects to Dandy-Walker malformation.14Barak T. Kwan K.Y. Louvi A. Demirbilek V. Saygı S. Tüysüz B. Choi M. Boyacı H. Doerschner K. Zhu Y. et al.Recessive LAMC3 mutations cause malformations of occipital cortical development.Nat. Genet. 2011; 43: 590-594Crossref PubMed Scopus (85) Google Scholar, 15Darbro B.W. Mahajan V.B. Gakhar L. Skeie J.M. Campbell E. Wu S. Bing X. Millen K.J. Dobyns W.B. Kessler J.A. et al.Mutations in extracellular matrix genes NID1 and LAMC1 cause autosomal dominant Dandy-Walker malformation and occipital cephaloceles.Hum. Mutat. 2013; 34: 1075-1079Crossref PubMed Scopus (28) Google Scholar, 16Radmanesh F. Caglayan A.O. Silhavy J.L. Yilmaz C. Cantagrel V. Omar T. Rosti B. Kaymakcalan H. Gabriel S. Li M. et al.Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.Am. J. Hum. Genet. 2013; 92: 468-474Abstract Full Text Full Text PDF PubMed Scopus (77) Google Scholar, 17Vigliano P. Dassi P. Di Blasi C. Mora M. Jarre L. LAMA2 stop-codon mutation: merosin-deficient congenital muscular dystrophy with occipital polymicrogyria, epilepsy and psychomotor regression.Eur. J. Paediatr. Neurol. 2009; 13: 72-76Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar Recessive LAMA2 mutations are the primary cause of CMD with occasional occipital polymicrogyria and epilepsy as a result of a complete lack of merosin, a component of the skeletal-muscle extracellular matrix protein laminin-2.17Vigliano P. Dassi P. Di Blasi C. Mora M. Jarre L. LAMA2 stop-codon mutation: merosin-deficient congenital muscular dystrophy with occipital polymicrogyria, epilepsy and psychomotor regression.Eur. J. Paediatr. Neurol. 2009; 13: 72-76Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar Recessive mutations in LAMB1 and LAMC3 each cause occipital cobblestone malformation, whereas mutations in LAMB1 additionally cause cerebellar vermis and brain stem hypoplasia with variable ocular defects and occasional occipital cephalocele.14Barak T. Kwan K.Y. Louvi A. Demirbilek V. Saygı S. Tüysüz B. Choi M. Boyacı H. Doerschner K. Zhu Y. et al.Recessive LAMC3 mutations cause malformations of occipital cortical development.Nat. Genet. 2011; 43: 590-594Crossref PubMed Scopus (85) Google Scholar, 16Radmanesh F. Caglayan A.O. Silhavy J.L. Yilmaz C. Cantagrel V. Omar T. Rosti B. Kaymakcalan H. Gabriel S. Li M. et al.Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.Am. J. Hum. Genet. 2013; 92: 468-474Abstract Full Text Full Text PDF PubMed Scopus (77) Google Scholar Heterozygous LAMC1 mutations cause Dandy-Walker malformation and occipital cephalocele.15Darbro B.W. Mahajan V.B. Gakhar L. Skeie J.M. Campbell E. Wu S. Bing X. Millen K.J. Dobyns W.B. Kessler J.A. et al.Mutations in extracellular matrix genes NID1 and LAMC1 cause autosomal dominant Dandy-Walker malformation and occipital cephaloceles.Hum. Mutat. 2013; 34: 1075-1079Crossref PubMed Scopus (28) Google Scholar Strikingly, none of these phenotypes includes the cerebellar cysts that are prominent in individuals with LAMA1 mutations. Laminins are extracellular matrix proteins required for basement membrane assembly and critical for early embryonic development.18Domogatskaya A. Rodin S. Tryggvason K. Functional diversity of laminins.Annu. Rev. Cell Dev. Biol. 2012; 28: 523-553Crossref PubMed Scopus (241) Google Scholar In mice, LAMA1 localizes exclusively in basement membranes, including within the mesenchyme adjacent to the developing cerebellum.19Sasaki T. Giltay R. Talts U. Timpl R. Talts J.F. Expression and distribution of laminin alpha1 and alpha2 chains in embryonic and adult mouse tissues: an immunochemical approach.Exp. Cell Res. 2002; 275: 185-199Crossref PubMed Scopus (93) Google Scholar Mice with homozygous knockout of Lama1 die in the early embryonic period as a result of impaired epiblast differentiation.20Schéele S. Falk M. Franzén A. Ellin F. Ferletta M. Lonai P. Andersson B. Timpl R. Forsberg E. Ekblom P. Laminin alpha1 globular domains 4-5 induce fetal development but are not vital for embryonic basement membrane assembly.Proc. Natl. Acad. Sci. USA. 2005; 102: 1502-1506Crossref PubMed Scopus (54) Google Scholar However, Lama1-conditional-knockout mice that overcome this early lethality have motor and coordination deficits and an overproliferation of granule cell precursors and subsequent excessive cell death, leading to mislocalization of granule cells and an overall reduced size of the adult cerebellum.21Heng C. Lefebvre O. Klein A. Edwards M.M. Simon-Assmann P. Orend G. Bagnard D. Functional role of laminin α1 chain during cerebellum development.Cell Adhes. Migr. 2011; 5: 480-489Crossref PubMed Scopus (18) Google Scholar, 22Ichikawa-Tomikawa N. Ogawa J. Douet V. Xu Z. Kamikubo Y. Sakurai T. Kohsaka S. Chiba H. Hattori N. Yamada Y. Arikawa-Hirasawa E. Laminin α1 is essential for mouse cerebellar development.Matrix Biol. 2012; 31: 17-28Crossref PubMed Scopus (45) Google Scholar In addition, the eye phenotypes described in mouse and zebrafish models parallel the findings described in our cohort. Hypomorphic and null Lama1 mutations in mice cause defects in the retinal inner limiting membrane, attenuated ERG, abnormal retinal vasculature, and progressive cell loss from the inner nuclear and ganglion cell layers.23Edwards M.M. Mammadova-Bach E. Alpy F. Klein A. Hicks W.L. Roux M. Simon-Assmann P. Smith R.S. Orend G. Wu J. et al.Mutations in Lama1 disrupt retinal vascular development and inner limiting membrane formation.J. Biol. Chem. 2010; 285: 7697-7711Crossref PubMed Scopus (63) Google Scholar, 24Edwards M.M. McLeod D.S. Grebe R. Heng C. Lefebvre O. Lutty G.A. Lama1 mutations lead to vitreoretinal blood vessel formation, persistence of fetal vasculature, and epiretinal membrane formation in mice.BMC Dev. Biol. 2011; 11: 60Crossref PubMed Scopus (32) Google Scholar Zebrafish lama1-mutant larvae exhibit attenuated ERG, lens and vasculature abnormalities, shortened and ectopic photoreceptor cells, and axon-guidance defects, whereas adult zebrafish mosaic for lama1 mutations exhibit cataracts, similar to the cataracts in UW160-4.25Biehlmaier O. Makhankov Y. Neuhauss S.C. Impaired retinal differentiation and maintenance in zebrafish laminin mutants.Invest. Ophthalmol. Vis. Sci. 2007; 48: 2887-2894Crossref PubMed Scopus (44) Google Scholar, 26Semina E.V. Bosenko D.V. Zinkevich N.C. Soules K.A. Hyde D.R. Vihtelic T.S. Willer G.B. Gregg R.G. Link B.A. Mutations in laminin alpha 1 result in complex, lens-independent ocular phenotypes in zebrafish.Dev. Biol. 2006; 299: 63-77Crossref PubMed Scopus (57) Google Scholar Further evaluation of the eye findings in individuals with LAMA1 mutations could reveal a distinctive phenotype that will be helpful for diagnosis in the future. Intriguingly, LAMA1 has also been proposed to be the relevant gene in the MYP2 locus associated with high myopia; however, two studies evaluating the association between high myopia and SNPs in LAMA1 yielded conflicting results.27Sasaki S. Ota M. Meguro A. Nishizaki R. Okada E. Mok J. Kimura T. Oka A. Katsuyama Y. Ohno S. et al.A single nucleotide polymorphism analysis of the LAMA1 gene in Japanese patients with high myopia.Clin. Ophthalmol. 2007; 1: 289-295PubMed Google Scholar, 28Zhao Y.Y. Zhang F.J. Zhu S.Q. Duan H. Li Y. Zhou Z.J. Ma W.X. Li Wang N. The association of a single nucleotide polymorphism in the promoter region of the LAMA1 gene with susceptibility to Chinese high myopia.Mol. Vis. 2011; 17: 1003-1010PubMed Google Scholar In addition to identifying LAMA1 mutations as the cause of the recently described, distinctive CDC phenotype, this work expands the CDC spectrum to include individuals with retinal dystrophy, mild cerebellar dysplasia, and no cysts. High myopia and large eye globes are also prevalent features. Of note, a homozygous LAMA1 frameshift mutation was identified in siblings (born to consanguineous parents) with a phenotypic description limited to “mild intellectual disability and strabismus,”29Najmabadi H. Hu H. Garshasbi M. Zemojtel T. Abedini S.S. Chen W. Hosseini M. Behjati F. Haas S. Jamali P. et al.Deep sequencing reveals 50 novel genes for recessive cognitive disorders.Nature. 2011; 478: 57-63Crossref PubMed Scopus (690) Google Scholar so it is unclear whether these individuals have CDC or whether LAMA1 loss of function can cause isolated intellectual disability. The combination of cerebellar vermis hypoplasia, abnormal superior cerebellar peduncles, and retinal dystrophy could result in misdiagnosis of Joubert syndrome. Although close examination of the retina and brain MRI might appropriately classify most individuals, genetic testing should be the most definitive way to separate the disorders. On the basis of the known mutations, we cannot identify genotype-phenotype correlations, given that the siblings with the mildest brain phenotype (UW163-3 and UW163-4) have a combination of a relatively early stop-gain mutation and a frameshift mutation. Finally, this work expands our understanding of the phenotypic spectrum associated with lamininopathy disorders and highlights the tissue-specific roles played by different laminin-encoding genes. We are grateful to all of the families who elected to participate in this study. This work was selected for study by the Care4Rare (Enhanced Care for Rare Genetic Diseases in Canada) Consortium Gene Discovery Steering Committee: Kym Boycott (lead; University of Ottawa), Alex MacKenzie (co-lead; University of Ottawa), Jacek Majewski (McGill University), Michael Brudno (University of Toronto), Dennis Bulman (University of Ottawa), and David Dyment (University of Ottawa). This work was funded in part by Genome Canada, the Canadian Institutes of Health Research, the Ontario Genomics Institute, the Ontario Research Fund, Genome Quebec, the Children’s Hospital of Eastern Ontario Foundation, Alberta Children’s Hospital Research Institute, and Alberta Innovates Health Solutions. The authors wish to acknowledge the contribution of the high-throughput sequencing platform of the McGill University and Genome Quebec Innovation Centre in Montreal. This work was also supported by the University of Washington Center for Mendelian Genomics (National Human Genome Research Institute award number U54HG006493), the Alberta Children’s Hospital Foundation, University of Washington School of Medicine Department of Pediatrics funds, private donations from families to the University of Washington Hindbrain Malformation Research Program, and the NIH National Institute for Neurological Disorders and Stroke under award number R01NS050375. The opinions and assertions contained herein are the views of the authors and are not to be construed as official or as reflecting the views of the United States Department of Defense. Download .pdf (.78 MB) Help with pdf files Document S1. Figures S1 and S2 and Tables S1 and S2 The URLs for data presented herein are as follows:1000 Genomes, http://browser.1000genomes.orgDatabase of Genomic Variants (DGV), http://dgv.tcag.ca/dgv/app/homeHomozygosityMapper, http://www.homozygositymapper.orgHuman Splicing Finder, http://www.umd.be/HSF3/index.htmlNHLBI Exome Sequencing Project (ESP) Exome Variant Server, http://evs.gs.washington.edu/EVS/Online Mendelian Inheritance in Man (OMIM), http://www.omim.orgRefSeq, http://www.ncbi.nlm.nih.gov/RefSeqUCSC Genome Browser, http://genome.ucsc.edu Mutations in LAMA1 Cause Cerebellar Dysplasia and Cysts with and without Retinal DystrophyAldinger et al.The American Journal of Human GeneticsOctober 02, 2014In Brief(The American Journal of Human Genetics 95, 227–234; August 7, 2014) Full-Text PDF Open Archive" @default.
- W1996340424 created "2016-06-24" @default.
- W1996340424 creator A5000758712 @default.
- W1996340424 creator A5000990352 @default.
- W1996340424 creator A5007833631 @default.
- W1996340424 creator A5009868462 @default.
- W1996340424 creator A5013851786 @default.
- W1996340424 creator A5013948006 @default.
- W1996340424 creator A5015673980 @default.
- W1996340424 creator A5021002499 @default.
- W1996340424 creator A5028283839 @default.
- W1996340424 creator A5040878528 @default.
- W1996340424 creator A5053318440 @default.
- W1996340424 creator A5053441512 @default.
- W1996340424 creator A5055447596 @default.
- W1996340424 creator A5056086829 @default.
- W1996340424 creator A5057687128 @default.
- W1996340424 creator A5063607432 @default.
- W1996340424 creator A5063661244 @default.
- W1996340424 creator A5065051535 @default.
- W1996340424 creator A5070884536 @default.
- W1996340424 date "2014-08-01" @default.
- W1996340424 modified "2023-10-18" @default.
- W1996340424 title "Mutations in LAMA1 Cause Cerebellar Dysplasia and Cysts with and without Retinal Dystrophy" @default.
- W1996340424 cites W1594586402 @default.
- W1996340424 cites W1656094290 @default.
- W1996340424 cites W1977314183 @default.
- W1996340424 cites W1981575540 @default.
- W1996340424 cites W2002178288 @default.
- W1996340424 cites W2007510388 @default.
- W1996340424 cites W2024422974 @default.
- W1996340424 cites W2030957276 @default.
- W1996340424 cites W2068958813 @default.
- W1996340424 cites W2071108036 @default.
- W1996340424 cites W2074078425 @default.
- W1996340424 cites W2081186262 @default.
- W1996340424 cites W2087454813 @default.
- W1996340424 cites W2091698674 @default.
- W1996340424 cites W2092910882 @default.
- W1996340424 cites W2096537373 @default.
- W1996340424 cites W2100148038 @default.
- W1996340424 cites W2104230245 @default.
- W1996340424 cites W2106496381 @default.
- W1996340424 cites W2132123037 @default.
- W1996340424 cites W2134174393 @default.
- W1996340424 cites W2138196920 @default.
- W1996340424 cites W2140227716 @default.
- W1996340424 cites W2166657289 @default.
- W1996340424 doi "https://doi.org/10.1016/j.ajhg.2014.07.007" @default.
- W1996340424 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4185116" @default.
- W1996340424 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25105227" @default.
- W1996340424 hasPublicationYear "2014" @default.
- W1996340424 type Work @default.
- W1996340424 sameAs 1996340424 @default.
- W1996340424 citedByCount "84" @default.
- W1996340424 countsByYear W19963404242014 @default.
- W1996340424 countsByYear W19963404242015 @default.
- W1996340424 countsByYear W19963404242016 @default.
- W1996340424 countsByYear W19963404242017 @default.
- W1996340424 countsByYear W19963404242018 @default.
- W1996340424 countsByYear W19963404242019 @default.
- W1996340424 countsByYear W19963404242020 @default.
- W1996340424 countsByYear W19963404242021 @default.
- W1996340424 countsByYear W19963404242022 @default.
- W1996340424 countsByYear W19963404242023 @default.
- W1996340424 crossrefType "journal-article" @default.
- W1996340424 hasAuthorship W1996340424A5000758712 @default.
- W1996340424 hasAuthorship W1996340424A5000990352 @default.
- W1996340424 hasAuthorship W1996340424A5007833631 @default.
- W1996340424 hasAuthorship W1996340424A5009868462 @default.
- W1996340424 hasAuthorship W1996340424A5013851786 @default.
- W1996340424 hasAuthorship W1996340424A5013948006 @default.
- W1996340424 hasAuthorship W1996340424A5015673980 @default.
- W1996340424 hasAuthorship W1996340424A5021002499 @default.
- W1996340424 hasAuthorship W1996340424A5028283839 @default.
- W1996340424 hasAuthorship W1996340424A5040878528 @default.
- W1996340424 hasAuthorship W1996340424A5053318440 @default.
- W1996340424 hasAuthorship W1996340424A5053441512 @default.
- W1996340424 hasAuthorship W1996340424A5055447596 @default.
- W1996340424 hasAuthorship W1996340424A5056086829 @default.
- W1996340424 hasAuthorship W1996340424A5057687128 @default.
- W1996340424 hasAuthorship W1996340424A5063607432 @default.
- W1996340424 hasAuthorship W1996340424A5063661244 @default.
- W1996340424 hasAuthorship W1996340424A5065051535 @default.
- W1996340424 hasAuthorship W1996340424A5070884536 @default.
- W1996340424 hasBestOaLocation W19963404241 @default.
- W1996340424 hasConcept C104317684 @default.
- W1996340424 hasConcept C118487528 @default.
- W1996340424 hasConcept C2775894508 @default.
- W1996340424 hasConcept C2777017193 @default.
- W1996340424 hasConcept C2780827179 @default.
- W1996340424 hasConcept C501734568 @default.
- W1996340424 hasConcept C54355233 @default.
- W1996340424 hasConcept C71924100 @default.
- W1996340424 hasConcept C86803240 @default.
- W1996340424 hasConceptScore W1996340424C104317684 @default.
- W1996340424 hasConceptScore W1996340424C118487528 @default.
- W1996340424 hasConceptScore W1996340424C2775894508 @default.